ROICAM is a series of events that consist of symposia, workshops, plenary session, ISHMO meetings, scientific poster competition and essay competition. Our speaker are hematology and medical oncology consultant , internal medicine specialist, surgery specialist, radiotherapy specialist, pathology specialist, radiology specialist, anesthesiologist, oncology nurses, health policy makers and other specialists in the field of cancer, both national and international levels.
This symposium will focus on delivering topics with multidisciplinary approach and case-based real experience approach. ROICAM has been routinely carried out for six consecutive years since 2012. The ROICAM 6th , conducted on August 2018, was registered by 840 participants and attended by 85% of them. We also had 6 workshops, 3 plenary lectures, 3 plenary symposiums, and 10 parallel symposiums with 7 international speakers and 73 national speakers.
Now, we will present the ROICAM 7th on 18-21 July 2019 to you.
Normal cells divide in an orderly way. They die when they are worn out or damaged, and new cells take their place. Cancer is when the cells start to grow out of control. The cancer cells keep on growing and making new cells. They crowd out normal cells.
Some cancers grow and spread fast. Others grow more slowly. Cancer cells can also spread to other parts of the body. Because of that cancer is not just one disease. Cancer is a systemic disease, highly heterogenic, and very complex.
Many cancers can be cured, but not all of them and not always. The most common treatments for cancer are surgery, chemotherapy, and radiation. Nowadays, targeted therapy , hormonal therapy, immunotherapy, and transplantation become a promising way to cure cancer
According to estimates from the World Health Organization (WHO) in 2015, Cancer is the first or second leading cause of death before age 70 years in 91 of 172 countries, and it ranks third or fourth in an additional 22 countries.
It is estimated that there will be 18.1 million new cases (17.0 million excluding non melanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding non melanoma skin cancer) worldwide in 2018. (GLOBOCAN 2018)
It is estimated that in Indonesia there will be 350,000 new cases and 208,000 cancer deaths in 2018. (GLOBOCAN 2018)
1. Bone Disorder in Cancer: Diagnosis and Therapy
2. Anticoagulant as A Prevention and Therapy
3. Targeted Therapy for Cancer Patient
4. Metastatic Breast Cancer (MBC): What Can We Do?
5. Hodgkin Lymphoma: How to Diagnose?
6. Non-Hodgkin Lymphoma: Early Treatment and Prognosis
7. Comprehensive Treatment of Colorectal Cancer
8. Early Detection in Most Frequent Cancer
9. Gastric Cancer: Most Misdiagnosed Cancer
10. Update Guideline and Therapy of B Cell Malignancies
11. Palliative Care and Treatment
Get yourself back to your best shape with our hands on workhop.
1. Chemotherapy for Internist
2. Management Nutrition in Cancer Patient
3. Chemotherapy-Induced Nausea and Vomiting (CINV)
4. Chemotherapy Related Febrile Neutropenia
5. Thrombosis: Prophylaxis and Treatment
7. Emergency in Oncology: Tumor Lysis Syndrome
A) Patient Safety and Ethics
B) The Journey of Lung Cancer Treatment
C) Blood Transfusion: Adverse Event Management (Requirement, Preparation, Therapy)
D) Thrombocytopenia Event in Cancer Patient: How to Treat?
Get the best practices from the best experts in the fields.
1. Perioperative Anticoagulant
2. Medical Bleeding Management
3. Anemia in Cancer
4. Hormon Resistant Metastatic Breast Cancer
Take a little break with our additional programs, including:
1. POI/YKI Survivor
2. Curriculum and Competencies for Indonesian Doctors in Multidisciplinary Team Era
3. Delegation Night
Join our Sharing Happiness Through Healthy Life Campaign, which includes:
1. Group Exercise and awareness campaign
2. Talkshow: Survivorship
Rumah Sakit Kanker Dharmais, Jakarta
Rumah Sakit Cipto Mangunkusumo, Jakarta